Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indocyanine Green NIR imaging of breast cancer margins after tumorectomy
2013-005178-23Phase 2Completed
- Sponsor
- Institut Jules Bordet
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of indocyanine green in breast cancer, sponsored by Institut Jules Bordet. Primary endpoint: Ability of NIR imaging to visualize tumoral volumes and tissues including operative margins. Started Dec 2013; status: completed.
02
Drugs
indocyanine green
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2013-005178-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005178-23.